Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HOXA-AS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101929552 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FSHR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR89A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf168 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RABGEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EZR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAA15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF213 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRIQ3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on